嗜麦芽窄食单胞菌
医学
抗生素
革兰氏阴性细菌感染
重症监护医学
重症监护室
菌血症
寡养单胞菌
血流
碳青霉烯
内科学
铜绿假单胞菌
微生物学
细菌
生物
假单胞菌
遗传学
作者
Zeynep Gökçe Gayretli Aydın,Gönül Tanır,Gülsüm İclal Bayhan,Türkan Aydın Teke,Özge Metin Akcan,Ayşe Kaman,Sevgi Yaşar Durmuş,Fatma Nur Öz
标识
DOI:10.1097/inf.0000000000002800
摘要
Background: Stenotrophomonas maltophilia , is a nonfermentative, aerobic, Gram-negative bacilli which is intrinsically resistance to several antibiotics. Treatment options for this bacteria are quite different from the other Gram-negative bacilli, which can represent a therapeutic challenge. To initiate appropriate empiric treatment and to reduce mortality, differentiation of S. maltophilia from other Gram-negative bacteria is critically important. The aim of this study is to distinguish the risk factors of S. maltophilia blood stream infections (BSI) from other Gram-negative BSI. Methods: This was a retrospective, case-control study. Patients with S. maltophilia BSI were selected as cases and patients with non- S. maltophilia Gram-negative BSI were selected as controls. Demographic and clinical characteristics of patients were recorded. Results: Forty-eight cases with S. maltophilia BSI and 144 controls were enrolled in the study. Risk factors for S. maltophilia BSI compared with the control group includes prior use of antibiotics, especially carbapenem, pediatric intensive care unit stay, mechanical ventilator use, indwelling catheters and duration of hospitalization. Conclusions: Breakthrough infection by S. maltophilia can occur in severely ill patients being treated with carbapenem. In the presence of risk factors, to reduce morbidity and mortality, S. maltophilia should be kept in mind when starting empiric treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI